Withdrawal of Infliximab or Concomitant Immunosuppressant Therapy in Patients With Crohn's Disease on Combination Therapy (SPARE): A Multicentre, Open-Label, Randomised Controlled Trial

被引：0
|
作者：
Louis, E.
Resche-Rigon, M.
Laharie, D.
机构：
来源：
DISEASES OF THE COLON & RECTUM | 2023年 / 66卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1520 / 1521
页数：2
相关论文
共 50 条
  • [21] Yoga therapy on elderly patients with fear of fall: an open-label randomised controlled trial (YOFEAR trial)
    Kashyap, Kritartha
    Dhar, Minakshi
    Bisht, Khushboo
    Bahurupi, Yogesh
    Pathania, Monika
    BMJ OPEN, 2023, 13 (12):
  • [22] Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn's disease (Review)
    Boyapati, Ray K.
    Torres, Joana
    Palmela, Carolina
    Parker, Claire E.
    Silverberg, Orli M.
    Upadhyaya, Sonam D.
    Nguyen, Tran M.
    Colombel, Jean-Frederic
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (05):
  • [23] Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open-label, prospective and randomised clinical trial
    Roblin, X.
    Boschetti, G.
    Williet, N.
    Nancey, S.
    Marotte, H.
    Berger, A.
    Phelip, J. M.
    Peyrin-Biroulet, L.
    Colombel, J. F.
    Del Tedesco, E.
    Paul, S.
    Flourie, B.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (02) : 142 - 149
  • [24] Randomised open-label controlled trial of ciprofloxacin/doxycycline/hydroxychloroquine combination compared with standard budesonide in active Crohn's disease (APRICOT)
    Rhodes, J. M.
    Subramanian, S.
    Flanagan, P.
    Horgan, G.
    Martin, K.
    Mansfield, J.
    Parkes, M.
    Hart, A.
    Dallal, H.
    Iqbal, T.
    Butterworth, J.
    Culshaw, K.
    Probert, C.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S487 - S487
  • [25] First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: an open-label multicentre randomised controlled trial
    Jongsma, Maria M. E.
    Aardoom, Martine A.
    Cozijnsen, Martinus A.
    van Pieterson, Merel
    de Meij, Tim
    Groeneweg, Michael
    Norbruis, Obbe F.
    Wolters, Victorien M.
    van Wering, Herbert M.
    Hojsak, Iva
    Kolho, Kaija-Leena
    Hummel, Thalia
    Stapelbroek, Janneke
    van der Feen, Cathelijne
    van Rheenen, Patrick F.
    van Wijk, Michiel P.
    Teklenburg-Roord, Sarah T. A.
    Schreurs, Marco W. J.
    Rizopoulos, Dimitris
    Doukas, Michail
    Escher, Johanna C.
    Samsom, Janneke N.
    de Ridder, Lissy
    GUT, 2022, 71 (01) : 34 - 42
  • [26] Intensive drug therapy versus standard drug therapy for symptomatic intestinal Crohn's disease strictures (STRIDENT): an open-label, single-centre, randomised controlled trial
    Schulberg, Julien D.
    Wright, Emily K.
    Holt, Bronte A.
    Hamilton, Amy L.
    Sutherland, Tom R.
    Ross, Alyson L.
    Vogrin, Sara
    Miller, Ashley M.
    Connell, William C.
    Lust, Mark
    Ding, Nik S.
    Moore, Gregory T.
    Bell, Sally J.
    Shelton, Edward
    Christensen, Britt
    De Cruz, Peter
    Rong, Yuwei J.
    Kamm, Michael A.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (04): : 318 - 331
  • [27] Infliximab for pediatric patients with Crohn's disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan
    Tajiri, Hitoshi
    Motoya, Satoshi
    Kinjo, Fukunori
    Maemoto, Atsuo
    Matsumoto, Takayuki
    Sato, Noriko
    Yamada, Hiroshi
    Nagano, Mieko
    Susuta, Yutaka
    Ozaki, Kunihiko
    Kondo, Kazuoki
    Hibi, Toshifumi
    PLOS ONE, 2018, 13 (08):
  • [28] Infliximab and leflunomide combination therapy in rheumatoid arthritis: an open-label study
    Kiely, PDW
    Johnson, DM
    RHEUMATOLOGY, 2002, 41 (06) : 631 - 637
  • [29] Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
    Gelber, Allan C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (11): : 1086 - 1086
  • [30] Safety and efficacy of infliximab therapy in active Behcet's uveitis: an open-label trial
    Al-Rayes, H.
    Al-Swailem, R.
    Al-Balawi, M.
    Al-Dohayan, N.
    Al-Zaidi, S.
    Tariq, M.
    RHEUMATOLOGY INTERNATIONAL, 2008, 29 (01) : 53 - 57
12345